Literature DB >> 23758216

Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama Study.

A Hata1, Y Doi, T Ninomiya, N Mukai, Y Hirakawa, J Hata, M Ozawa, K Uchida, T Shirota, T Kitazono, Y Kiyohara.   

Abstract

AIMS: Early studies have shown that magnesium intake decreases the risk of Type 2 diabetes, but the results are still inconsistent. We prospectively examined the association between magnesium intake and incidence of Type 2 diabetes in a general Japanese population.
METHODS: A total of 1999 subjects without diabetes aged 40-79 years who underwent a 75-g oral glucose tolerance test were followed up prospectively for a mean of 15.6 years.
RESULTS: During the follow-up, 417 subjects developed Type 2 diabetes. The age- and sex-adjusted incidence of Type 2 diabetes significantly decreased with increasing magnesium intake quartile levels (≤ 148.5, 148.6-171.5, 171.6-195.5 and ≥ 195.6 mg/day, P for trend = 0.01). In multivariate analyses, after adjusting for comprehensive risk factors and other dietary factors, the hazard ratio of Type 2 diabetes was 0.67 (95% CI 0.49-0.92; P = 0.01) in the third quartile and 0.63 (95% CI 0.44-0.90; P = 0.01) in the highest quartile compared with the first quartile. In addition, the risk of Type 2 diabetes was 14% lower (P = 0.04) for a 1-sd increment of log-transformed magnesium intake in the multivariate-adjusted model. In stratified analysis, there were statistically significant interactions between magnesium intake and levels of homeostasis model assessment of insulin resistance, high-sensitivity C-reactive protein or alcohol intake on the risk of Type 2 diabetes (all P < 0.05).
CONCLUSIONS: Our findings suggest that increased magnesium intake was a significant protective factor for the incidence of Type 2 diabetes in the general Japanese population, especially among subjects with insulin resistance, low-grade inflammation and a drinking habit.
© 2013 The Authors. Diabetic Medicine © 2013 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23758216     DOI: 10.1111/dme.12250

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  28 in total

1.  Effects of pistachio nut supplementation on blood glucose in patients with type 2 diabetes: a randomized crossover trial.

Authors:  Mahmoud Parham; Saeide Heidari; Ashraf Khorramirad; Mohammad Hozoori; Fatemeh Hosseinzadeh; Lida Bakhtyari; Jamshid Vafaeimanesh
Journal:  Rev Diabet Stud       Date:  2014-08-10

Review 2.  Seaweeds as potential therapeutic interventions for the metabolic syndrome.

Authors:  Senthil Arun Kumar; Lindsay Brown
Journal:  Rev Endocr Metab Disord       Date:  2013-09       Impact factor: 6.514

3.  A new method to evaluate the dose-effect relationship of a TCM formula Gegen Qinlian Decoction: "Focus" mode of integrated biomarkers.

Authors:  Zhi-Qiang Huang; Xue-Mei Fan; Yi-Ming Wang; Qiong-Lin Liang; Xiao-Lin Tong; Yu Bai; Ying-Meng Li; Guo-An Luo; Chao Chen
Journal:  Acta Pharmacol Sin       Date:  2017-03-20       Impact factor: 6.150

Review 4.  Japanese Clinical Practice Guideline for Diabetes 2019.

Authors:  Eiichi Araki; Atsushi Goto; Tatsuya Kondo; Mitsuhiko Noda; Hiroshi Noto; Hideki Origasa; Haruhiko Osawa; Akihiko Taguchi; Yukio Tanizawa; Kazuyuki Tobe; Narihito Yoshioka
Journal:  Diabetol Int       Date:  2020-07-24

5.  Dietary magnesium intake and the risk of diabetes in the Japanese community: results from the Takayama study.

Authors:  Kie Konishi; Keiko Wada; Takashi Tamura; Michiko Tsuji; Toshiaki Kawachi; Chisato Nagata
Journal:  Eur J Nutr       Date:  2015-12-21       Impact factor: 5.614

6.  Japanese Clinical Practice Guideline for Diabetes 2019.

Authors:  Eiichi Araki; Atsushi Goto; Tatsuya Kondo; Mitsuhiko Noda; Hiroshi Noto; Hideki Origasa; Haruhiko Osawa; Akihiko Taguchi; Yukio Tanizawa; Kazuyuki Tobe; Narihito Yoshioka
Journal:  J Diabetes Investig       Date:  2020-07       Impact factor: 4.232

7.  Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis.

Authors:  D T Dibaba; P Xun; A D Fly; K Yokota; K He
Journal:  Diabet Med       Date:  2014-11       Impact factor: 4.359

8.  Retrospective study of factors associated with progression and remission/regression of diabetic kidney disease-hypomagnesemia was associated with progression and elevated serum alanine aminotransferase levels were associated with remission or regression.

Authors:  Tatsuo Yanagawa; Keiko Koyano; Koichiro Azuma
Journal:  Diabetol Int       Date:  2021-01-02

9.  Magnesium intake is inversely associated with the risk of metabolic syndrome in the REasons for geographic and racial differences in stroke (REGARDS) cohort study.

Authors:  Daniel T Dibaba; Cheng Chen; Liping Lu; Aurelian Bidulescu; Alyce D Fly; Pengcheng Xun; Suzanne E Judd; Mary Cushman; Ka Kahe
Journal:  Clin Nutr       Date:  2020-10-21       Impact factor: 7.324

10.  Changes in Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus in Middle School Students: Using Data from the HEALTHY Study.

Authors:  Manal Naseeb; Michael L Bruneau; Brandy-Joe Milliron; Deeptha Sukumar; Gary D Foster; Sinclair A Smith; Stella L Volpe
Journal:  J Nutr       Date:  2021-11-02       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.